Combined rituximab and belimumab to treat recalcitrant epidermolysis bullosa aquisita associated with systemic lupus erythematosus.

Autor: Tull TJ; St John's Institute of Dermatology., Benton EC; St John's Institute of Dermatology., Semkova K; St John's Institute of Dermatology., Watson NA; Ear, Nose and Throat Department., Mee JB; St John's Institute of Dermatology., Lopez B; Louise Coote Lupus Unit., Setterfield J; St John's Institute of Dermatology., Carey B; St John's Institute of Dermatology., Ahmad S; Moorfields Eye Hospital NHS Foundation Trust, London, UK., Robbie SJ; Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust., Groves RW; St John's Institute of Dermatology., Sanna G; Louise Coote Lupus Unit., D'Cruz DP; Louise Coote Lupus Unit.
Jazyk: angličtina
Zdroj: The British journal of dermatology [Br J Dermatol] 2024 Jun 20; Vol. 191 (1), pp. 138-140.
DOI: 10.1093/bjd/ljae141
Abstrakt: Competing Interests: Conflicts of interest The authors declare no conflicts of interest.
Databáze: MEDLINE